Navigation Links
KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Company's ADHD Prodrug Technology
Date:8/25/2010

ess, timelines, plans of our clinical and preclinical programs, and potential benefits of KemPharm Inc.'s product candidates, involve various assumptions, known and unknown risks, and uncertainties which may cause actual results or events to be materially different and adverse from those expressed in or implied by the forward-looking statements.  Such assumptions, risks and uncertainties may relate to difficulties or delays in discovery, development, testing, and regulatory approval of the company's product candidates, results that are inconsistent with preclinical results, unexpected adverse side effects, or inadequate therapeutic efficacy of the product candidates.  The forward-looking statements in this release speak only as of this date, and KemPharm disclaims any obligation to update publicly any forward-looking statement to reflect the occurrence of events or circumstances after the date hereof.Contacts:KemPharm, Inc.Kate Holt, Ph.D.319-665-2575E-mail: info@kempharm.com
'/>"/>
SOURCE KemPharm, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. KemPharm, Inc. Receives Notice of Issuance From USPTO on Patent Protecting Companys ADHD Prodrug Technology
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. CryoCor Receives FDA Approval for Right Atrial Flutter
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... , April 28, 2015 ... Berlin and the Charité creates ... as a central research location   ... technical and medical information products and services, has announced ... the Humboldt University (Humboldt-Universität), the Free University of ...
(Date:4/28/2015)... WILMINGTON, N.C. , April 28, 2015 ... of the Year (CRoY) winners in the UK, joining the ... earned the Gold Pharma in the CTA category and ... Both Chiltern Source professionals are working with Novartis. ... this recognition as top performers in the industry," commented ...
(Date:4/28/2015)...   GenSpera, Inc. (OTCQB: GNSZ) announced ... has issued U.S. Patent No. 8,957,016. This patent ... for the company,s prodrugs designed to be activated ... GenSpera is developing a series of prodrugs that ... from the poisonous plant, Thapsia garganica . The ...
Breaking Medicine Technology:Elsevier and the Friedrich-Althoff Consortium Collaborate to Create "Archive of Berlin" as a Basis for a Common Research Infrastructure 2Elsevier and the Friedrich-Althoff Consortium Collaborate to Create "Archive of Berlin" as a Basis for a Common Research Infrastructure 3Chiltern expands PharmaTimes Clinical Researcher of the Year involvement as sponsor, host and winner 2Chiltern expands PharmaTimes Clinical Researcher of the Year involvement as sponsor, host and winner 3GenSpera Granted New Patent for Prodrugs Activated by Prostate Specific Antigen 2
(Date:4/28/2015)... 2015 Wimbledon Health Partners, the ... electrocardiogram, echocardiogram, and NCV testing, has expanded their ... help podiatrists diagnose peripheral arterial disease (PAD). ... without the aid of vascular testing,” said ... at Wimbledon Health Partners. “Diminished peripheral pulses, atrophic ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Once considered an ... Lights have taken the industry by storm with perfectly tailored ... use unit. , More than half of every ... KIND LED , proving the stigma is gone and LED ... overwhelming positive response from customers and their first hand experience ...
(Date:4/28/2015)... “ Gwee ” was featured on ... features the latest and coolest technology products available to ... for NewsWatch, conducted the review and shared with viewers ... As much as everyone loves their tablets, it’s annoying ... looking at them, it's even more annoying trying to ...
(Date:4/28/2015)... The Awareness Counselor team has introduced a new ... According to Awareness Counselor, there are ramifications of judging. Judging ... to an individual who self-judges. This new concept is now ... or one one one talk. , The premise of this ... that every being on earth is here for a purpose ...
(Date:4/28/2015)... Henderson, NV (PRWEB) April 28, 2015 ... University's Center for Ethics (June 27, 2014), prescription ... the world. Medical Science is becoming increasingly aware of ... on the market, such as chemotherapy drugs to treat ... bacteria that are quickly evolving to become increasingly resistant ...
Breaking Medicine News(10 mins):Health News:Podiatrists Affiliate with Wimbledon Health Partners to Diagnose Peripheral Arterial Disease 2Health News:SuperCloset Reports Surge in KIND LED Grow Light Sales, Saving Indoor Growing Enthusiasts up to 40% on their Power Usage. 2Health News:The Most Innovative iPad Case was Featured on NewsWatch Television 2Health News:What Happens When We Judge Ourselves and Others? – A New Concept Introduced 2Health News:What Happens When We Judge Ourselves and Others? – A New Concept Introduced 3Health News:Trivedi Science™ Announces the Beginning of Their Science Research to Create Highly Effective Pharmaceutical Drugs with Minimal Side Effects 2Health News:Trivedi Science™ Announces the Beginning of Their Science Research to Create Highly Effective Pharmaceutical Drugs with Minimal Side Effects 3Health News:Trivedi Science™ Announces the Beginning of Their Science Research to Create Highly Effective Pharmaceutical Drugs with Minimal Side Effects 4
... Partners is being recognized as one of the top performing California ... year. HealthCare Partners is one of only four California Physicians groups ... , ... (PRWEB) November 11, 2008 -- This is the ...
... Awareness Month--The Apo E Gene Diet--A Solution for ... Other Chronic Illnesses. ,THE APO E GENE DIET ... and Weight Loss" category of National Best Books ... E Gene Diet presents an integrative medicine solution ...
... The 2008 Frost &,Sullivan European Health Ingredient ... in recognition of its pioneering efforts in developing ... "Rather than cure, current medical treatments for ... pain," notes Frost & Sullivan,Research Analyst Kaushik Ghosh. ...
... Nov. 10 KV Pharmaceutical Company,(NYSE: KVa/KVb) announced today ... the Company will be delayed in the filing of,its ... The Company expects to,file a Form 12b-25 Notice of ... November 12, 2008., About KV Pharmaceutical Company, ...
... announced,today that the Company Chief Executive Officer, Steve ... pipeline, at the Rodman &,Renshaw,s 10th Annual Healthcare ... EST at the New York Palace Hotel, 455 ... is a private drug development Company,founded in 1996 ...
... HARRISBURG, Pa., Nov. 10 State agriculture,and health officials ... about important food safety issues made four stops in,northeastern ... Health Secretary Michael,Huff visited the area as part of ... which is a comprehensive plan to address,food safety and ...
Cached Medicine News:Health News:HealthCare Partners Rated A 'Top Performing California Physician Group' By IHA For the Fifth Straight Year 2Health News:HealthCare Partners Rated A 'Top Performing California Physician Group' By IHA For the Fifth Straight Year 3Health News:The Apo E Gene Diet--Preventing, Alzheimer's and Heart Disease, One Patient at a Time 2Health News:The Apo E Gene Diet--Preventing, Alzheimer's and Heart Disease, One Patient at a Time 3Health News:The Apo E Gene Diet--Preventing, Alzheimer's and Heart Disease, One Patient at a Time 4Health News:Frost & Sullivan Honours GELITA for Developing European Health Ingredient of the Year 2Health News:Frost & Sullivan Honours GELITA for Developing European Health Ingredient of the Year 3Health News:KV Pharmaceutical to File Form 12b-25 on November 12, 2008 2Health News:KV Pharmaceutical to File Form 12b-25 on November 12, 2008 3Health News:KV Pharmaceutical to File Form 12b-25 on November 12, 2008 4Health News:Agriculture, Health Officials Address Food Safety Concerns During Northeastern PA Tour 2
Compact benchtop clinical chemistry system...
... The VITROS 350 Chemistry System offers easy ... as a primary, STAT, or back-up to the ... System will get the job done right the ... that VITROS Systems are efficient, dependable, and easy-to-use. ...
Meet Galileo, the best reason to move to automation; the best way to upgrade your capabilities....
... gel sample slots 0.4 mm or larger ... flexible, autoclavable, precision tapered polycarbonate tips (T ... contact sample. Includes 6 tips (0.34 ... plastic spacer. Comp ...
Medicine Products: